#Pulnovo_Medical
LightNews LightNews
newsen.bsky.social
Pulnovo Medical Achieves Important IDE Approvals for PADN Clinical Trials#Shanghai#USA#Clinical_Trials#Pulnovo_Medical#PADN_System
Pulnovo Medical Achieves Important IDE Approvals for PADN Clinical Trials
Pulnovo Medical is set to advance its PADN system for pulmonary hypertension as it gets two IDE approvals, enabling further clinical trials and CMS coverage.
third-news.com
September 12, 2025 at 10:28 AM
newsen.bsky.social
Pulnovo Medical Achieves Significant Milestone with Two IDE Approvals for PADN Clinical Trials#Shanghai#None#Pulmonary_Hypertension#Pulnovo_Medical#PADN_System
Pulnovo Medical Achieves Significant Milestone with Two IDE Approvals for PADN Clinical Trials
Pulnovo Medical has received IDE approvals for the PADN system, enabling crucial clinical trials for pulmonary hypertension with full CMS coverage.
third-news.com
September 12, 2025 at 10:18 AM
newsen.bsky.social
Pulnovo Medical Achieves IDE Approval for Clinical Trials on PADN System with CMS Coverage#Shanghai#USA#Pulnovo_Medical#PADN_System#CMS_Coverage
Pulnovo Medical Achieves IDE Approval for Clinical Trials on PADN System with CMS Coverage
Pulnovo Medical has secured IDE approval for clinical trials focusing on its PADN system, which aims to treat pulmonary hypertension, with full coverage by CMS.
third-news.com
September 13, 2025 at 11:46 AM
newsen.bsky.social
Pulnovo Medical Obtains IDE Approvals for PADN Clinical Trials with CMS Coverage#Shanghai#USA#Clinical_Trials#Pulnovo_Medical#PADN
Pulnovo Medical Obtains IDE Approvals for PADN Clinical Trials with CMS Coverage
Pulnovo Medical has secured two IDE approvals for the PADN system's clinical trials, paving the way for significant advancements in treating pulmonary hypertension and heart failure.
third-news.com
September 12, 2025 at 7:05 PM
newsen.bsky.social
Pulnovo Medical Achieves Essential IDE Approvals for PADN Clinical Trials with Full CMS Coverage#Shanghai#United_States#CMS#Pulnovo_Medical#IDE_Approvals
Pulnovo Medical Achieves Essential IDE Approvals for PADN Clinical Trials with Full CMS Coverage
Pulnovo Medical has received important IDE approvals for its PADN system, allowing clinical trials in patients with pulmonary hypertension and heart failure in the U.S.
third-news.com
September 12, 2025 at 3:27 PM
newsen.bsky.social
Pulnovo Medical Unveils Significant Findings from the PADN-HF-PH Trial During ESC Congress 2026#Shanghai#USA#Pulnovo_Medical#ESC_Congress#PADN-HF-PH
Pulnovo Medical Unveils Significant Findings from the PADN-HF-PH Trial During ESC Congress 2026
Pulnovo Medical has revealed impressive outcomes from the PADN-HF-PH trial, highlighting a breakthrough in managing pulmonary hypertension linked to left heart disease, now published in NEJM.
third-news.com
September 3, 2026 at 12:23 PM
newsen.bsky.social
Pulnovo Medical Unveils Groundbreaking PADN-HF-PH Trial Results at ESC Congress 2026#Shanghai#USA#Pulnovo_Medical#PADN#Hipertensión_Pulmonar
Pulnovo Medical Unveils Groundbreaking PADN-HF-PH Trial Results at ESC Congress 2026
Pulnovo Medical has announced pivotal results from its PADN-HF-PH clinical trial at ESC Congress 2026, revealing significant clinical improvements and groundbreaking findings.
third-news.com
September 3, 2026 at 7:48 PM
newsen.bsky.social
Pulnovo Medical's Groundbreaking Clinical Trial in Pulmonary Hypertension Presented at ESC 2026#Shanghai#USA#Pulnovo_Medical#PADN#ESC_2026
Pulnovo Medical's Groundbreaking Clinical Trial in Pulmonary Hypertension Presented at ESC 2026
Pulnovo Medical announces impressive results from the PADN-HF-PH trial, showing significant clinical improvements in pulmonary hypertension. Key findings include a 51% reduction in clinical worsening risk.
third-news.com
September 3, 2026 at 8:10 PM
newsen.bsky.social
Pulnovo Medical Presents Groundbreaking PADN-HF-PH Study Findings at ESC 2026 and NEJM#Shanghai#USA#Pulmonary_Hypertension#Pulnovo_Medical#PADN-HF-PH
Pulnovo Medical Presents Groundbreaking PADN-HF-PH Study Findings at ESC 2026 and NEJM
Pulnovo Medical unveiled significant results from the PADN-HF-PH study, demonstrating major advancements in treating pulmonary hypertension at ESC 2026.
third-news.com
September 3, 2026 at 7:51 PM
newsen.bsky.social
Pulnovo Medical's PADN-HF-PH Trial Reveals Groundbreaking Insights at ESC 2026#Shanghai#USA#Pulnovo_Medical#ESC_Congress#PADN-HF-PH
Pulnovo Medical's PADN-HF-PH Trial Reveals Groundbreaking Insights at ESC 2026
Discover how Pulnovo Medical's PADN-HF-PH trial results showcased at ESC Congress 2026 promise revolutionary advancements in heart failure treatment, published in NEJM.
third-news.com
September 3, 2026 at 12:23 PM
newsen.bsky.social
Pulnovo Medical Takes a Major Step Forward in Treating Pulmonary Hypertension with Initial Patient Enrollment#United_States#Detroit#Pulmonary_Hypertension#Pulnovo_Medical#PULSE-LHD
Pulnovo Medical Takes a Major Step Forward in Treating Pulmonary Hypertension with Initial Patient Enrollment
Pulnovo Medical has successfully enrolled its first two patients in the PULSE-LHD clinical trial in the U.S., aiming to treat pulmonary hypertension linked to left heart disease. This marks a significant advancement in the field.
third-news.com
August 24, 2026 at 3:12 AM
newsen.bsky.social
Pulnovo Medical Secures $100 Million Financing Led by Medtronic for Innovative Cardiopulmonary Therapies#USA#New_York#Medtronic#Pulnovo_Medical#PADN_System
Pulnovo Medical Secures $100 Million Financing Led by Medtronic for Innovative Cardiopulmonary Therapies
Pulnovo Medical announced the successful closing of a $100 million funding round led by Medtronic, marking a significant milestone in its growth.
third-news.com
April 20, 2026 at 1:56 PM
newsen.bsky.social
Pulnovo Medical Secures $100 Million Investment from Medtronic to Advance Innovative Therapies#USA#New_York#Medtronic#Pulnovo_Medical#cardiac_therapies
Pulnovo Medical Secures $100 Million Investment from Medtronic to Advance Innovative Therapies
Pulnovo Medical has successfully completed a $100 million financing round led by Medtronic, enhancing its innovative pulmonary hypertension therapies and global presence.
third-news.com
April 20, 2026 at 12:49 PM
newsen.bsky.social
Pulnovo Medical Secures Strategic Investment from Medtronic in $100 Million Funding Round#USA#New_York#Medtronic#Pulnovo_Medical#PADN_Therapy
Pulnovo Medical Secures Strategic Investment from Medtronic in $100 Million Funding Round
Pulnovo Medical has announced a significant $100 million oversubscribed funding round, led by Medtronic, along with renewed support from existing investors and new partnerships, enhancing its growth trajectory.
third-news.com
April 20, 2026 at 12:48 PM
newsen.bsky.social
Pulnovo Medical Secures $100 Million Funding with Investment from Medtronic#United_States#New_York#Medtronic#Pulnovo_Medical#PADN_System
Pulnovo Medical Secures $100 Million Funding with Investment from Medtronic
Pulnovo Medical has successfully completed a $100 million financing round led by Medtronic, enhancing its growth in therapies for pulmonary hypertension.
third-news.com
April 20, 2026 at 12:09 AM
newsen.bsky.social
Pulnovo Medical Secures $100 Million Investment from Medtronic to Propel Global Expansion#USA#New_York#Medtronic#Pulnovo_Medical#PADN_System
Pulnovo Medical Secures $100 Million Investment from Medtronic to Propel Global Expansion
Pulnovo Medical has completed a $100 million financing round led by Medtronic, marking a significant step in advancing heart disease therapies and global reach.
third-news.com
April 20, 2026 at 12:09 AM
newsen.bsky.social
Pulnovo Medical Enhances Leadership with Dr. Francis Duhay as CMO#China#Shanghai#CMO#Pulnovo_Medical#Dr._Francis_Duhay
Pulnovo Medical Enhances Leadership with Dr. Francis Duhay as CMO
Pulnovo Medical bolsters its executive team by appointing Dr. Francis Duhay as Global Chief Medical Officer, aiming for innovation in therapies for pulmonary hypertension.
third-news.com
August 25, 2025 at 8:39 AM
newsen.bsky.social
Pulnovo Medical Welcomes EQT as New Investor After CE-MDR Approval for Innovative Cardiac Device#Hong_Kong#Pulnovo_Medical#Qiming_Venture#EQT_Group
Pulnovo Medical Welcomes EQT as New Investor After CE-MDR Approval for Innovative Cardiac Device
Pulnovo Medical recently announced EQT as its new investor, aiming to expand treatment options for pulmonary hypertension and heart failure patients globally with continued backing from Qiming Venture Partners.
third-news.com
May 21, 2025 at 3:30 PM
newsen.bsky.social
Pulnovo Medical Welcomes EQT as New Investor Following CE Approval#None#Clinical_Trials#Pulnovo_Medical#EQT_Group
Pulnovo Medical Welcomes EQT as New Investor Following CE Approval
Pulnovo Medical announces EQT Group as its new investor after receiving CE certification, enhancing options for pulmonary hypertension treatment globally.
third-news.com
May 21, 2025 at 3:18 PM
newsen.bsky.social
Pulnovo Medical Welcomes New Investor EQT Following CE-MDR Approval to Expand Pulmonary Hypertension Solutions#USA#EQT#HongKong#Qiming_Venture_Partners#Pulnovo_Medical
Pulnovo Medical Welcomes New Investor EQT Following CE-MDR Approval to Expand Pulmonary Hypertension Solutions
Pulnovo Medical announces its new partnership with EQT after obtaining CE-MDR certification, aiming to enhance treatment options for pulmonary hypertension patients.
third-news.com
May 21, 2025 at 3:17 PM
newsen.bsky.social
Pulnovo Medical Announces New Investment by EQT to Advance Global Expansion Following CE-MDR Certification#EQT#None#Qiming_Venture_Partners#Pulnovo_Medical
Pulnovo Medical Announces New Investment by EQT to Advance Global Expansion Following CE-MDR Certification
Pulnovo Medical secures a new investment from EQT to expand treatment options for pulmonary hypertension globally, following CE-MDR approval.
third-news.com
May 20, 2025 at 8:49 AM
newsen.bsky.social
Pulnovo Medical Secures Nearly $100 Million in Series C Funding Round for Heart Disease Innovations#Shanghai#USA#Heart_Failure#Pulnovo_Medical#PADN_Technology
Pulnovo Medical Secures Nearly $100 Million in Series C Funding Round for Heart Disease Innovations
Pulnovo Medical has successfully raised nearly $100 million in Series C funding, aimed at enhancing global clinical trials and expanding international businesses.
third-news.com
March 4, 2025 at 3:27 AM
newsen.bsky.social
Pulnovo Medical Secures Nearly $100 Million in Series C Financing for Innovative Medical Solutions#Shanghai#USA#Heart_Failure#Pulnovo_Medical#PADN_Technology
Pulnovo Medical Secures Nearly $100 Million in Series C Financing for Innovative Medical Solutions
Pulnovo Medical has announced the successful closure of nearly $100 million in a Series C funding round, aimed at advancing treatments for pulmonary hypertension and heart failure.
third-news.com
March 4, 2025 at 3:26 AM
newsen.bsky.social
Pulnovo Medical Secures Nearly $100 Million in Series C Funding to Advance Heart Failure Treatments#Shanghai#USA#Heart_Failure#Pulnovo_Medical#PADN_Technology
Pulnovo Medical Secures Nearly $100 Million in Series C Funding to Advance Heart Failure Treatments
Pulnovo Medical has successfully closed a Series C funding, raising nearly $100 million to enhance clinical trials for pulmonary hypertension treatments.
third-news.com
March 4, 2025 at 3:26 AM
newsen.bsky.social
Pulnovo Medical Secures Nearly $100 Million in Series C Financing to Advance Heart Health Innovations#China#Shanghai#Pulnovo_Medical#PADN#Qiming_Venture
Pulnovo Medical Secures Nearly $100 Million in Series C Financing to Advance Heart Health Innovations
Pulnovo Medical successfully concludes its nearly $100 million Series C financing round, aiming for global expansion and innovative heart treatment advances in pulmonary hypertension.
third-news.com
March 3, 2025 at 12:09 AM